SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to positive interim data from its RAD 101 Phase 2b imaging trial, sparking significant community discussion around the potential for a short squeeze and high price targets. The stock's impressive pre-market surge and subsequent volatility have traders weighing the potential for further gains against the risk of a pullback. A forthcoming webinar is adding to the anticipation, with many speculating on its impact on the stock's direction.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to speculation of a potential short squeeze, with community members actively discussing strategies to push the stock higher and liquidate shorts. The stock's high volatility and recent price action are fueling the conversation, as traders compare it to other low-float stocks that have experienced significant surges. Some are noting the company's small market cap and low float, which could contribute to rapid price movements.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending downwards, driven by sector-wide concerns about an AI bubble and delayed data center projects, despite a major Microsoft deal. Community sentiment is divided, with some calling the stock a "scam" and expecting further declines, while others view the dip as a buying opportunity, citing strong fundamentals and long-term growth potential. Discussions also revolve around potential market manipulation and the stock's correlation with Bitcoin's price movements.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chun Sing Chan on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings is trending as traders discuss its low float and potential for a short squeeze, drawing comparisons to other HK stocks that have seen explosive runs. Community members are highlighting the company's recent acquisitions and revenue, anticipating news that could catalyze a significant price movement. Some traders caution against FOMO due to the stock's volatility and low volume.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple's stock is trending amid discussions around its AI strategy and potential partnerships, particularly after some analysts suggested it's lagging behind competitors. The community is debating whether Apple's lower AI spending is a strength or weakness, with some viewing it as a safe haven play. Additionally, there's speculation about Apple's next moves in response to increasing competition and evolving market dynamics.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is trending as community members discuss the potential impact of autonomous driving tests and analyst upgrades. Bullish sentiment is fueled by the possibility of Tesla achieving new highs, while bears express concerns about valuation. Options activity and overall market conditions are also contributing to the conversation around the stock.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

OMER is trending as investors anticipate a potential FDA approval for Narsoplimab by late December, with the community actively discussing the likelihood of approval and potential buyout scenarios. Recent price action and large put buys have sparked speculation about a possible news leak or market manipulation. Bullish investors express confidence in the drug's efficacy and Novo Nordisk's backing, viewing any price dips as buying opportunities.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending as investors digest news of a potential $19.5 billion write-down related to its EV strategy, with community discussions focusing on the implications of scaling back EV investments and shifting towards hybrids. Some view this pullback as a pragmatic move aligning with current market demand and improving profitability, while others question the company's leadership and long-term EV commitment. Broader conversations include the impact on Tesla and potential industry-wide EV write-downs.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

TTD is trending as investors discuss its recent QQQ removal and significant YTD decline, leading to debates about tax-loss harvesting and potential bottom fishing. Community members are weighing the impact of these factors against the company's fundamentals and future prospects in the ad tech space. Discussions also involve the company's leadership and strategic direction amidst competitive pressures.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending as the community rallies around its meme-driven culture and consistent presence, emphasizing fun and organic growth on the Solana blockchain. Community members highlight the coin's unique ability to maintain bullish vibes regardless of market conditions, promoting it as a 'virus' that is both inevitable and enjoyable to embrace. Discussions also revolve around the coin's potential for long-term growth, particularly looking ahead to 2026, and its growing presence in the meme space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Frazier Life Sciences Management L.P. Increases Stock Position in Agios Pharmaceuticals, Inc. $AGIO

Frazier Life Sciences Management L.P. raised its stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 19.6% in the 2nd quarter, according to its most recent Form 13F filing with the...

Agios Pharmaceuticals, Inc. $AGIO Shares Purchased by Bellevue Group AG

Bellevue Group AG raised its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 2.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities...

Armistice Capital LLC Has $38.85 Million Holdings in Agios Pharmaceuticals, Inc. $AGIO

Armistice Capital LLC decreased its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 43.0% in the 2nd quarter, according to its most recent 13F filing with the SEC...

Agios Awaits Pyrukynd Decision in Thalassemia as FDA Misses Due Date

AGIO faces uncertainty as the FDA misses its Dec. 7 deadline related to the sNDA for Pyrukynd in thalassemia and offers no new timeline.

Marshall Wace LLP Purchases 163,796 Shares of Agios Pharmaceuticals, Inc. $AGIO

Marshall Wace LLP boosted its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 31.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the...

Futures Rise For 10th Day In Past 11 With Fed Rate Cut Looming

Futures Rise For 10th Day In Past 11 With Fed Rate Cut Looming With just 17 trading sessions left in 2025, stock futures edge higher again and are on pace for 10 gains in the past 11 days. S&P 500...

Prudential Financial Inc. Lowers Holdings in Agios Pharmaceuticals, Inc. $AGIO

Prudential Financial Inc. reduced its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 22.5% in the 2nd quarter, according to the company in its most recent disclosure...

Envestnet Asset Management Inc. Reduces Holdings in Agios Pharmaceuticals, Inc. $AGIO

Envestnet Asset Management Inc. lowered its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 55.2% in the second quarter, according to its most recent filing with the...

FY2026 EPS Estimates for AGIO Increased by Cantor Fitzgerald

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Analysts at Cantor Fitzgerald increased their FY2026 earnings per share estimates for Agios Pharmaceuticals in a research note issued on...

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the twelve ratings firms that are currently covering the...

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Current Price	$26.85
Prev Close	$27.27
Open	$27.60
Dividend Yield	0.00%
50-Day Moving Average	$36.99
Beta	1.15
Avg. Volume	2.4M
PE Ratio	-3.92

52-Week High	$46.00
52-Week Low	$22.24
Market Capitalization	$2.02B
EPS (Annual)	$11.64
Price to Book	1.24
Revenue Per Employee	$74,790.98
Enterprise Value/EBITDA	N/A

AGIO
Agios Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AGIO News

AGIOAgios Pharmaceuticals Inc